Libertyville, IL, United States of America

Andrew J Souers

USPTO Granted Patents = 63 (Patent Applications = 70)

CIPO Patents = 12 (Patent Applications = 37)

EPO Patents = 27 (Patent Applications = 46)

Average Co-Inventor Count = 8.4

ph-index = 14

Forward Citations = 660(Granted Patents)

Forward Citations (Not Self Cited) = 500(Oct 12, 2025)

Inventors with similar research interests:

Location History:

Evanston, IL (US) (2005 - 2024)
Libertyville, IL (US) (2015 - 2024)

Company Filing History:

Abbott Laboratories Corporation

The Walter and Eliza Hall Institute of Medical Research

patents

5. 1 out of 1

The Walter and Eliza Hall Medical Research Institute

patent

6. 1 out of 1

The Walter and Eliza Institute of Medical Research

patent

where one patent can have more than one assignee

Years Active: 2005-2024

Loading Chart...

63 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11964990 - 1,3,4,7-tetrahydro-2H-pyrrolo[3′,2′:5,6]pyrido[2,3-b][1,4]oxazepine bcl-2 inhibitors (2024-04-23),

2. 11897864 - Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases (2024-02-13),

3. 11786519 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2023-10-17),

4. 11759527 - Anti-EGFR antibody-drug conjugates (2023-09-19),

5. 10676485 - Macrocyclic MCL-1 inhibitors and methods of use (2020-06-09),

6. 10640563 - Anti-B7-H3 antibodies and antibody drug conjugates (2020-05-05),

7. 10081628 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2018-09-25),

8. 9877958 - Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases (2018-01-30),

9. 9872861 - Methods of treatment using selective Bcl-2 inhibitors (2018-01-23),

10. 9844547 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2017-12-19),

11. 9796708 - Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors (2017-10-24),

12. 9650358 - Pyridine CDK9 kinase inhibitors (2017-05-16),

13. 9403822 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2016-08-02),

14. 9359296 - 7-substituted indole Mcl-1 inhibitors (2016-06-07),

15. 9346813 - Substituted pyrrolo[2,3-d]pyrimindines as CDK9 kinase inhibitors (2016-05-24),

Title: The Innovations of Andrew J Souers: A Profile of a Visionary Inventor

Introduction: Andrew J Souers, based in Libertyville, IL, is an accomplished inventor with an impressive portfolio of 63 patents. His innovations primarily focus on advancements in pharmaceutical compounds aimed at treating various cancers and autoimmune diseases. Souers has demonstrated a commitment to enhancing therapeutic options for patients through his extensive work in the pharmaceutical industry.

Latest Patents: Among Souers' notable inventions are significant formulations such as the 1,3,4,7-tetrahydro-2H-pyrrolo[3′,2′:5,6]pyrido[2,3-b][1,4]oxazepine bcl-2 inhibitors. This patent presents compounds effective in treating chronic lymphocytic leukemia (CLL), small lymphocytic leukemia (SLL), and acute lymphoblastic leukemia (ALL). Additionally, he has developed apoptosis-inducing agents to combat cancer and diseases characterized by the expression of anti-apoptotic Bcl-2 proteins, which play a crucial role in the development of various cancers.

Career Highlights: Andrew J Souers has made significant contributions while employed by prominent companies in the pharmaceutical sector, including AbbVie Inc. and Abbott Laboratories Corporation. His tenure at these organizations has allowed him to collaborate with leading experts in the field and to drive forward innovative projects aimed at improving patient care.

Collaborations: Throughout his career, Souers has worked alongside esteemed colleagues, including Zhi-Fu Tao and Steven Elmore. These collaborations have fostered a creative and productive environment that has yielded groundbreaking research and successful patents.

Conclusion: Andrew J Souers exemplifies the spirit of innovation within the pharmaceutical industry. His dedicated contributions, as evidenced by his numerous patents and collaborations, have played a vital role in advancing therapeutic agents for significant health challenges. As he continues to push the boundaries of science, his work not only enhances the field of pharmacology but also stands to improve countless lives around the world.

This text is generated by artificial intelligence and may not be accurate.